Form 8-K Sarepta Therapeutics, For: Jul 19
Tweet
Share
E-mail
http://archive.fast-edgar.com/20160719/A32Z822IZZ2R82Z222JS2CXP9PQTZZ22DI82
Filed on: July 19, 2016
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
- VALLOUREC CONFIRMS ITS INTENTION TO RETURN CLOSE TO €650 MILLION TO SHAREHOLDERS IN 2026 FOLLOWING THE COMPLETION OF ITS SHARE BUYBACK PROGRAM AND THE FULL EXERCISE OF THE WARRANTS
- Mirantis First to Future-Proof AI Infrastructure with Integrated Day-Zero Support for Current and Next-Generation NVIDIA Architectures
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
